Literature DB >> 17966221

Hysteroscopy with directed biopsy versus dilatation and curettage for the diagnosis of endometrial hyperplasia and cancer in perimenopausal women.

R Bedner1, I Rzepka-Górska.   

Abstract

BACKGROUND: The present study was undertaken to compare the effectiveness of dilatation and curretage (D&C) with hysteroscopy and guided biopsy (H+B) for the collection of endometrial samples adequate for histological examination in perimenopausal women at risk of endometrial hyperplasia or cancer.
METHODS: We performed hysteroscopy and biopsy followed by dilatation and curettage in 734 patients with abnormal perimenopausal bleeding or sonographically revealed endometrial pathology. Two hundred and ninety-two patients in whom lesions were totally removed during hysteroscopy were excluded from further study.
RESULTS: Using both methods we disclosed 64 cases of endometrial polyps, 60 cases of endometrial hyperplasia, and 49 cases of endometrial cancer. Hysteroscopy left just four cases of endometrial pathology undiagnosed as opposed to 21 cases using dilatation and curettage. Histology could not be performed on material obtained with hysteroscopy in four cases and with curettage in 23 cases.
CONCLUSIONS: 1) Hysteroscopy with directed biopsy is more sensitive in disclosing all types of uterine lesions than dilatation and curettage. 2) Curettage done after hysteroscopy and directed biopsy does not improve the detection of endometrial cancer.

Entities:  

Mesh:

Year:  2007        PMID: 17966221

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  9 in total

1.  Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasia.

Authors:  Monica Hagan Vetter; Blair Smith; Jason Benedict; Erinn M Hade; Kristin Bixel; Larry J Copeland; David E Cohn; Jeffrey M Fowler; David O'Malley; Ritu Salani; Floor J Backes
Journal:  Am J Obstet Gynecol       Date:  2019-08-08       Impact factor: 8.661

Review 2.  Uterine distension media for outpatient hysteroscopy.

Authors:  Karim S Abdallah; Moustafa A Gadalla; Maria Breijer; Ben Willem J Mol
Journal:  Cochrane Database Syst Rev       Date:  2021-11-26

3.  Controversies in the management of endometrial cancer.

Authors:  V Masciullo; G Amadio; D Lo Russo; I Raimondo; A Giordano; G Scambia
Journal:  Obstet Gynecol Int       Date:  2010-06-16

4.  Magnetic resonance imaging for detection of depth of myometrial invasion and cervical invasion in patients with endometrial carcinoma.

Authors:  Xiang-Hua Yin; Hong-Yan Jia; Min Shi; Huan Wu; Yun-Mo Li
Journal:  Int J Clin Exp Med       Date:  2015-10-15

5.  Concordance between the Hysteroscopic Diagnosis of Endometrial Hyperplasia and Histopathological Examination.

Authors:  Pasquale De Franciscis; Gaetano Riemma; Antonio Schiattarella; Luigi Cobellis; Maria Guadagno; Salvatore Giovanni Vitale; Lavinia Mosca; Antonio Cianci; Nicola Colacurci
Journal:  Diagnostics (Basel)       Date:  2019-10-07

Review 6.  Controversy on Positive Peritoneal Cytology of Endometrial Carcinoma.

Authors:  Yi-Si Liu; Hui-Min Wang; Yan Gao
Journal:  Comput Math Methods Med       Date:  2022-04-01       Impact factor: 2.238

7.  Office Hysteroscopy as a Valid Tool for Diagnosis of Genital Tract Lesions in Females with Intact Hymen.

Authors:  Hui-Yu Huang; Yi-Ting Huang; Kai-Yun Wu; Yu-Ying Su; Cindy Hsuan Weng; Chin-Jung Wang
Journal:  Biomed Res Int       Date:  2019-11-11       Impact factor: 3.411

Review 8.  Hysteroscopy in the management of endometrial hyperplasia and cancer in reproductive aged women: new developments and current perspectives.

Authors:  Salvatore Giovanni Vitale; Gaetano Riemma; Jose Carugno; Benito Chiofalo; George Angelos Vilos; Stefano Cianci; Mehmet Sukru Budak; Bernardo Portugal Lasmar; Antonio Raffone; Ilker Kahramanoglu
Journal:  Transl Cancer Res       Date:  2020-12       Impact factor: 1.241

Review 9.  Preoperative assessment of endometrial cancer.

Authors:  Péter Török; Zoárd Krasznai; Szabolcs Molnár; Rudolf Lampé; Attila Jakab
Journal:  Transl Cancer Res       Date:  2020-12       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.